Global Health Diplomacy: A Comparative Analysis of China’s and the U.S.’s Soft Power during COVID-19 and the myth of Thucydides Trap

Abstract

The emergence of COVID-19 has provided a new vigor to addressed global health issues. In this regard, global health diplomacy initiatives have seen a considerable surge. Countries around the world are using the opportunity to harness the potential of global health diplomacy in cultivating relations with several countries and also building a soft power projection. A case in point is how China has been spearheading global health efforts to improve relations while projecting a soft power about how China aims to act as global savior. Chinese efforts were able to gain significant traction owing to the fact that the United States under the administration of President Trump suspended its global leadership role, the first such instance in the post-World War-II era. This paper explains the concept of global health diplomacy by conducting a comparative analysis of the global health efforts and policies undertaken by both the United States and China by following qualitative research technique and secondary sources to explain the phenomenon. The study found that China led the response to COVID-19 not only domestically but globally as well. The U.S. lagged but gradually started to compete China in health diplomacy. There is an evident struggle for dominance in health sector between China and the U.S., however, it is not expected to lead into hard power struggle. The paper has concluded that it is important for both countries to work together in future in case of pandemic to spearhead an international effort against such crises. Moreover, it recommends Chinese authorities to include health corridor as a component with Belt and Road Initiative. On the other hand, the United States under the administration of President Joe Biden should invest in multilateral efforts so to empower global health institutions to better prepare for future health crises.